Autoantibodies and microglia: boon or bane?
Open Access
- 1 August 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Brain
- Vol. 144 (8), 2231-2233
- https://doi.org/10.1093/brain/awab269
Abstract
This scientific commentary refers to ‘MOG autoantibodies trigger a tightly controlled FcR and BTK-driven microglia proliferative response’ by Pellerin et al. (doi:10.1093/brain/awab231).Funding Information
- Wellcome Institutional Strategic Fund
- Queen’s University Belfast
This publication has 9 references indexed in Scilit:
- MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative responseBrain, 2021
- IgG Immune Complexes Break Immune Tolerance of Human MicrogliaThe Journal of Immunology, 2020
- Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis opticaMultiple Sclerosis and Related Disorders, 2020
- Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritisProceedings of the National Academy of Sciences of the United States of America, 2020
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- Systemic Inflammation Modulates Fc Receptor Expression on Microglia during Chronic NeurodegenerationThe Journal of Immunology, 2011
- Fcγ receptors as regulators of immune responsesNature Reviews Immunology, 2008
- Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptorsProceedings of the National Academy of Sciences of the United States of America, 2006
- B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic MiceThe Journal of Experimental Medicine, 1998